Summer Research Administrative Supplement to 1R01GM128186-01, Transforming Life Sciences: Artificial Life
Summer Research Administrative Supplement to 1R01GM128186-01, Transforming Life Sciences: Artificial Life
批准号:
10393839
负责人:
STEVEN A BENNER
金额:
$1.2万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-01 至 2022-08-31
关键词:
Administrative SupplementAreaAwardBiological SciencesBiologyBiomedical ResearchBiomimeticsBiotechnologyCellsChemistryClinical MedicineDNADNA-Directed DNA PolymeraseDiagnosticDoctor of PhilosophyEducational process of instructingEngineeringEnsureEscherichia coliFloridaFoundationsFundingFutureGenerationsGeneticHydrogen BondingInformation SystemsLaboratory ResearchLettersLifeMedicalMedicineMetabolicMissionMolecular BiologyMolecular EvolutionNucleotidesPaperPolymeraseProtein EngineeringPublicationsPublishingPurinesPyrimidinePyrimidinesRNA-Directed DNA PolymeraseResearchRunningScienceScientistTalentsTechnologyTherapeutic AgentsTimeTrainingUnited States National Institutes of HealthUniversitiesWorkXenobioticsanalogbasecareercold temperatureexperiencegenetic informationimprovedoutreachparent projectprogramsrecruitsummer researchsynthetic biologyundergraduate researchundergraduate student
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Summer Research Administrative Supplement to 1R01GM128186-01
Transforming Life Sciences: Artificial Life
Foundation for Applied Molecular Evolution
Steven A. Benner
ABSTRACT
In addition to its research, teaching, and outreach activities, the Foundation for Applied Molecular Evolution
runs a program that offers opportunities for laboratory research experience to undergraduates seeking careers
in medicine, biotechnology, and biomedical research. In the past few years, undergraduate trainees have gone
on to MD-PhD programs (Michael Durante, Oleg Uryasev, Jennifer Le), to start biotech enterprises (Heshan
Illangkoon), and to pursue Ph.D. degrees (Marc Neveu). All published papers from their undergraduate
research.
Here, we seek an administrative supplement for summer 2021 to support Justin Kim, an undergraduate from
the University of Florida. The supplement will provide him his first experience in protein engineering in an
area (DNA polymerases) that has applications not only to the project that this proposal supplements, but also
can be applied in diagnostics, in the generation of therapeutic agents, and in biotechnology.
The project that he will join (1R01GM128186-01) is a Director's Transformative project that seeks to create an
artificial life form (a “xenobiotic” known as SEGUE). This xenobiotic will reproduce much of what we value in
natural life but with a different core molecular biology. This is moving beyond “synthetic biology” and
“biomimetic chemistry”.
Specifically, SEGUE restructures the DNA of the living cell by adapting Watson-Crick pairing. In 4-letter
standard DNA, pairing follows two complementarity rules: (a) size (large purines pair with small pyrimidines)
and (b) hydrogen bonding (on purine pu and pyrimidine py ring analogs, hydrogen bond acceptors, A, pair
with donors D). Rearranging D and A groups on the bases creates artificially expanded genetic information
systems (AEGIS). The parent project involves creating new cells that replicate six-letter DNA, either GACTZP
DNA or GACTKX DNA. This is done by recruiting E. coli as a platform, and expanding its metabolic capabilities
to support six-letter replication.
Replication of 6-letter DNA is done by DNA polymerases. This project requires the engineering of these
polymerases to accept unnatural nucleotides, this project has led to the publication of many of these
polymerases. Many of them have been thermally stable, however. While these work well in PCR, they do not
perform as well at low temperature where E. coli lives. At the same time, various reverse transcriptases have
been recruited that do accept six letter genetic alphabets. Thus, this background lends itself to a single Aim:
Mr. Kim will use protein engineering on a diversity science platform to improve mesophilic DNA polymerases
that copy DNA built from six nucleotides. These polymerases will be used in cells being engineered to manage
and use expanded DNA, to be an integral part of the funded Director's Transformative Technology award.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Synthetic Biology Pathway to Nucleoside Triphosphates for Expanded Genetic Alphabets.
扩展遗传字母表的核苷三磷酸的合成生物学途径。
DOI:
10.1021/acssynbio.3c00060
发表时间:
2023
期刊:
ACS synthetic biology
影响因子:
4.7
作者:
[Li,Yubing, Abraham,Clay, Suslov,Oleg, Yaren,Ozlem, Shaw,RyanW, Kim,Myong-Jung, Wan,Shuo, Marliere,Philippe, Benner,StevenA]
通讯作者:
Benner,StevenA
Electrochemical Reduction and Oxidation of Eight Unnatural 2'-Deoxynucleosides at a Pyrolytic Graphite Electrode.
热解石墨电极上八种非天然 2-脱氧核苷的电化学还原和氧化。
DOI:
10.1016/j.electacta.2020.137210
发表时间:
2020
期刊:
Electrochimica acta
影响因子:
6.6
作者:
[Špaček,Jan, Karalkar,Nilesh, Fojta,Miroslav, Wang,Joseph, Benner,StevenA]
通讯作者:
Benner,StevenA
Basic Research for Diagnostics and Surveillance in Lower Resource Environments
-
批准号:10669039
-
项目类别:
-
资助金额:$67.11万
-
财政年份:2021
-
负责人:STEVEN A BENNER
-
依托单位:
Easily Used Kits to Evolve Reagents that Covalently Tag and Inactivate Proteins
-
批准号:10626917
-
项目类别:
-
资助金额:$31.39万
-
财政年份:2021
-
负责人:STEVEN A BENNER
-
依托单位:
Easily Used Kits to Evolve Reagents that Covalently Tag and Inactivate Proteins
-
批准号:10478279
-
项目类别:
-
资助金额:$31.39万
-
财政年份:2021
-
负责人:STEVEN A BENNER
-
依托单位:
Basic Research for Diagnostics and Surveillance in Lower Resource Environments
-
批准号:10468606
-
项目类别:
-
资助金额:$74.17万
-
财政年份:2021
-
负责人:STEVEN A BENNER
-
依托单位:
Enzymatic Synthesis of RNA
-
批准号:10456251
-
项目类别:
-
资助金额:$68.67万
-
财政年份:2021
-
负责人:STEVEN A BENNER
-
依托单位:
Easily Used Kits to Evolve Reagents that Covalently Tag and Inactivate Proteins
-
批准号:10298982
-
项目类别:
-
资助金额:$31.39万
-
财政年份:2021
-
负责人:STEVEN A BENNER
-
依托单位:
Enzymatic Synthesis of RNA
-
批准号:10631998
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2021
-
负责人:STEVEN A BENNER
-
依托单位:
Equipment Supplement to 1R01GM141391-01A1 (Easily Used Kits to Evolve Reagents that Covalently Tag and Inactivate Proteins)
-
批准号:10580301
-
项目类别:
-
资助金额:$13.5万
-
财政年份:2021
-
负责人:STEVEN A BENNER
-
依托单位:
Enzymatic Synthesis of RNA
-
批准号:10201263
-
项目类别:
-
资助金额:$77.42万
-
财政年份:2021
-
负责人:STEVEN A BENNER
-
依托单位:
PHS2019-02 Omnibus Solic of the NIH, CDC, and FDA for SBIR Apps No Clinical Trial (Parent SBIR R43/4
-
批准号:10476977
-
项目类别:
-
资助金额:$48.52万
-
财政年份:2021
-
负责人:STEVEN A BENNER
-
依托单位:
Reagents to Chemically Tag Specific Coronavirus Spike Proteins
-
批准号:10259048
-
项目类别:
-
资助金额:$25.89万
-
财政年份:2021
-
负责人:STEVEN A BENNER
-
依托单位:
PHS2019-02 Omnibus Solic of the NIH, CDC, and FDA for SBIR Apps No Clinical Trial (Parent SBIR R43/4
-
批准号:10081533
-
项目类别:
-
资助金额:$48.69万
-
财政年份:2021
-
负责人:STEVEN A BENNER
-
依托单位:
Nucleic Acid Innovations to Manage Pathogen Sequence Divergence
-
批准号:9375498
-
项目类别:
-
资助金额:$18.5万
-
财政年份:2017
-
负责人:STEVEN A BENNER
-
依托单位:
Transforming Life Sciences: Artificial Life
-
批准号:10238893
-
项目类别:
-
资助金额:$65.82万
-
财政年份:2017
-
负责人:STEVEN A BENNER
-
依托单位:
Transforming Life Sciences: Artificial Life
-
批准号:9764390
-
项目类别:
-
资助金额:$65.82万
-
财政年份:2017
-
负责人:STEVEN A BENNER
-
依托单位:
Synthetic Biology for Field Detection of Zika in the US and Abroad
-
批准号:9465786
-
项目类别:
-
资助金额:$15.0万
-
财政年份:2017
-
负责人:STEVEN A BENNER
-
依托单位:
Transforming Life Sciences: Artificial Life
-
批准号:10001047
-
项目类别:
-
资助金额:$65.82万
-
财政年份:2017
-
负责人:STEVEN A BENNER
-
依托单位:
Create Ultralong DNA Constructs in One Assembly Step
-
批准号:9754193
-
项目类别:
-
资助金额:$64.84万
-
财政年份:2016
-
负责人:STEVEN A BENNER
-
依托单位:
Eliminating Malaria from Haiti. Reinventing DNA to Eradicate Endemic Parasites
-
批准号:9202515
-
项目类别:
-
资助金额:$14.71万
-
财政年份:2016
-
负责人:STEVEN A BENNER
-
依托单位:
Simple Inexpensive Assay for Five Common HIV Resistance Mutations
-
批准号:8847160
-
项目类别:
-
资助金额:$16.96万
-
财政年份:2015
-
负责人:STEVEN A BENNER
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: